AI study to simplify consent forms
This trial tests if using an AI tool can help make study consent forms easier to understand. It includes patients, research staff, and ethics reviewers at UCLA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a UCLA patient aged 60 or older, a UCLA clinical trial staff member, or part of UCLA's Institutional Review Board (IRB).
- You must speak English.
- You can understand and agree to participate in this study.
- If you work on clinical trials at UCLA, you cannot be a lead investigator for one specific transplant study.
- If you are on the IRB, you must not have reviewed that same transplant study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether AI-simplified educational materials help parents understand their child's condition better than the original materials. It includes parents of children treated at Hospital for Special Surgery.
This trial tests an AI system for biomedical research. You may be able to join if you are an adult who can commit time and understand tasks.
This study tests new AI-created summaries of cancer imaging reports (like CT or MRI scans) that are written in plain language to help you better understand your results. Researchers want to see if these summaries help cancer patients and their doctors communicate more clearly about imaging findings.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This study tests if an AI tool can improve the safety review of radiation treatment plans for prostate cancer. Patients continue their normal treatment while the AI helps doctors check the plans.
This trial tests whether using artificial intelligence to guide treatment after one round of chemotherapy works better than standard treatment for a type of blood cancer called LBCL. You'll receive initial chemotherapy, then be assigned to either an AI-guided treatment plan or standard chemotherapy based on how well you respond.
Hear when a new Informed Consent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.